203 related articles for article (PubMed ID: 25564611)
1. Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.
Lecerf M; Scheel T; Pashov AD; Jarossay A; Ohayon D; Planchais C; Mesnage S; Berek C; Kaveri SV; Lacroix-Desmazes S; Dimitrov JD
J Biol Chem; 2015 Feb; 290(8):5203-5213. PubMed ID: 25564611
[TBL] [Abstract][Full Text] [Related]
2. Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes.
Llorente M; Sánchez-Palomino S; Mañes S; Lucas P; Kremer L; De Alborán IM; Torán JL; Alcamí J; Del Real G; Martínez-A C
Scand J Immunol; 1999 Sep; 50(3):270-9. PubMed ID: 10447936
[TBL] [Abstract][Full Text] [Related]
3. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.
Neshat MN; Goodglick L; Lim K; Braun J
Int Immunol; 2000 Mar; 12(3):305-12. PubMed ID: 10700465
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
[TBL] [Abstract][Full Text] [Related]
5. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
Front Immunol; 2018; 9():3163. PubMed ID: 30697215
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
[TBL] [Abstract][Full Text] [Related]
7. Nonrandom features of the human immunoglobulin variable region gene repertoire expressed in response to HIV-1.
Zouali M
Appl Biochem Biotechnol; 1996; 61(1-2):149-55. PubMed ID: 9100352
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120.
Bagley J; Dillon PJ; Rosen C; Robinson J; Sodroski J; Marasco WA
Mol Immunol; 1994 Oct; 31(15):1149-60. PubMed ID: 7935503
[TBL] [Abstract][Full Text] [Related]
9. Development of functional human monoclonal single-chain variable fragment antibody against HIV-1 from human cervical B cells.
Berry JD; Rutherford J; Silverman GJ; Kaul R; Elia M; Gobuty S; Fuller R; Plummer FA; Barbas CF
Hybrid Hybridomics; 2003 Apr; 22(2):97-108. PubMed ID: 12831535
[TBL] [Abstract][Full Text] [Related]
10. Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection.
Chan KW; Pan R; Costa M; Gorny MK; Wang S; Lu S; Kong XP
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997214
[TBL] [Abstract][Full Text] [Related]
11. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
[TBL] [Abstract][Full Text] [Related]
12. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
Akapirat S; Karnasuta C; Vasan S; Rerks-Ngarm S; Pitisuttithum P; Madnote S; Savadsuk H; Rittiroongrad S; Puangkaew J; Phogat S; Tartaglia J; Sinangil F; de Souza MS; Excler JL; Kim JH; Robb ML; Michael NL; Ngauy V; O'Connell RJ; Karasavvas N;
PLoS One; 2018; 13(4):e0196397. PubMed ID: 29702672
[TBL] [Abstract][Full Text] [Related]
14. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
[TBL] [Abstract][Full Text] [Related]
15. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
[TBL] [Abstract][Full Text] [Related]
16. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage.
Bowley DR; Labrijn AF; Zwick MB; Burton DR
Protein Eng Des Sel; 2007 Feb; 20(2):81-90. PubMed ID: 17242026
[TBL] [Abstract][Full Text] [Related]
17. Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire.
de Haard JJ; Kazemier B; Oudshoorn P; Boender P; van Gemen B; Koolen MJ; van der Groen G; Hoogenboom HR; Arends JW
J Gen Virol; 1998 Dec; 79 ( Pt 12)():2883-94. PubMed ID: 9880001
[TBL] [Abstract][Full Text] [Related]
18. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
19. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.
Koch M; Pancera M; Kwong PD; Kolchinsky P; Grundner C; Wang L; Hendrickson WA; Sodroski J; Wyatt R
Virology; 2003 Sep; 313(2):387-400. PubMed ID: 12954207
[TBL] [Abstract][Full Text] [Related]
20. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
